Literature DB >> 27088649

National Variability and Appropriateness of Surgical Antibiotic Prophylaxis in US Children's Hospitals.

Thomas J Sandora1, Monica Fung2, Patrice Melvin3, Dionne A Graham3, Shawn J Rangel4.   

Abstract

IMPORTANCE: Appropriate use of surgical antibiotic prophylaxis (AP) reduces surgical site infection rates, but prior data suggest variability in use patterns.
OBJECTIVE: To assess national variability and appropriateness of AP in pediatric surgical patients. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 31 freestanding children's hospitals in the United States using administrative data from 2010-2013. The study included 603 734 children younger than 18 years who underwent one of the 45 most commonly performed operations. EXPOSURES: Receipt of surgical AP. MAIN OUTCOMES AND MEASURES: Primary outcomes included procedure- and hospital-specific rates of AP use and appropriateness of use based on clinical guidelines and consensus statements. We also assessed rates of Clostridium difficile infection and potential allergic reactions (using epinephrine administration as a surrogate event) after AP receipt.
RESULTS: Of the 603 734 eligible patients, the mean (SD) patient age was 4.8 (4.4) years and 384 571 (63.7%) were boys. For the 671 255 operations evaluated, AP was administered for 348 119 (52%) of procedures. Intrahospital variation in AP use by procedure ranged from 11.5% to 100% (median, 78.1%). Overall, AP use was considered appropriate for 64.6% of cases. Appropriate use of AP by hospital varied from 47.3% to 84.4% with large variability by procedure within each hospital. For procedures for which AP was indicated, the median rate of appropriate use by hospital was 93.8%; however, for procedures for which AP was not indicated, the median rate of appropriate use by hospital was 52.0%. The odds of C difficile infection and epinephrine administration were significantly higher among children who received AP (odds ratio, 3.34; 95% CI, 1.66-6.73 and odds ratio 1.97; 95% CI, 1.92-2.02; respectively). CONCLUSIONS AND RELEVANCE: There is substantial national variability in the overall and appropriate use of AP for the most commonly performed operations in children both at a procedure and hospital level. A high proportion of AP use is inappropriate, potentially exposing many children to avoidable adverse events. Urgent attention should be directed to efforts to standardize the use of surgical AP in pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 27088649     DOI: 10.1001/jamapediatrics.2016.0019

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  6 in total

1.  Antibiotic Prophylaxis for Pyloromyotomy in Children: An Opportunity for Better Stewardship.

Authors:  Kibileri Williams; Timothy Lautz; Richard J Hendrickson; Tolulope A Oyetunji
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

2.  Preparing enhanced recovery after surgery for implementation in pediatric populations.

Authors:  Ira L Leeds; Emily F Boss; Jessica A George; Valerie Strockbine; Elizabeth C Wick; Eric B Jelin
Journal:  J Pediatr Surg       Date:  2016-09-05       Impact factor: 2.545

3.  Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile.

Authors:  Aubrey Balch; Aaron M Wendelboe; Sara K Vesely; Dale W Bratzler
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

Review 4.  Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next.

Authors:  Matthew P Kronman; Ritu Banerjee; Jennifer Duchon; Jeffrey S Gerber; Michael D Green; Adam L Hersh; David Hyun; Holly Maples; Colleen B Nash; Sarah Parker; Sameer J Patel; Lisa Saiman; Pranita D Tamma; Jason G Newland
Journal:  J Pediatric Infect Dis Soc       Date:  2018-08-17       Impact factor: 3.164

5.  A cluster randomized stepped-wedge trial to de-implement unnecessary post-operative antibiotics in children: the optimizing perioperative antibiotic in children (OPerAtiC) trial.

Authors:  Sara Malone; Virginia R McKay; Christina Krucylak; Byron J Powell; Jingxia Liu; Cindy Terrill; Jacqueline M Saito; Shawn J Rangel; Jason G Newland
Journal:  Implement Sci       Date:  2021-03-19       Impact factor: 7.327

6.  Barriers and Facilitators to Implementation of Antibiotic Stewardship Programmes in Hospitals in Developed Countries: Insights From Transnational Studies.

Authors:  Magdalena Rzewuska; Eilidh M Duncan; Jill J Francis; Andrew M Morris; Kathryn N Suh; Peter G Davey; Jeremy M Grimshaw; Craig R Ramsay
Journal:  Front Sociol       Date:  2020-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.